Skip to main content
Full access
Letters to the Editor
Published Online: 1 January 2008

Elevated Cardiac Risk in Patients With Major Depressive Disorder

To The Editor: In their most recent report of the Heart and Soul Study, published in the September 2007 issue of the Journal, Christian Otte, M.D., et al. documented an association between carriage of the s allele of the serotonin transporter polymorphism (5-HTTLPR) and elevated urinary norepinephrine levels (1) and, by inference, sympathetic nervous activation. This is an important observation and may explain the elevated cardiac risk in patients with major depressive disorder. Activation of the sympathetic outflow to the heart occurs in patients unexpectedly developing ventricular tachycardia and ventricular fibrillation (2) . Chronic sympathetic nervous activation may exert a trophic effect on cardiovascular growth, contributing to the development of left ventricular hypertrophy (3), which is an independent risk factor for cardiovascular morbidity and mortality (4) . Unfortunately, Dr. Otte et al. did not document the presence or absence of left ventricular hypertrophy in their cohort (1) .
It is important to appreciate that human sympathetic nervous activity is regionalized, with the outflow to some organs, such as the heart, sometimes being preferentially activated. Indeed, preferential activation of the cardiac sympathetic outflow occurs with experimental mental stress (5) . Urinary norepinephrine levels provide, at best, an imprecise index of global sympathetic nervous function. Using direct cardiac catheterization techniques coupled with norepinephrine isotope dilution methodology, we have recently demonstrated that sympathetic activity in patients with major depressive disorder follows a bimodal distribution, with values in some patients being extraordinarily high (6) . The degree of cardiac sympathetic activity in the “high” major depressive disorder group was comparable with that observed in subjects following laboratory mental stress (5) . Following selective serotonin reuptake inhibitor therapy, sympathetic nervous activity was significantly reduced only in those patients with excessively elevated sympathetic tone. Whether the bimodality in sympathetic activity in major depressive disorder that we observed was associated with the s or l allele of the 5-HTTLPR remains unknown but obviously merits attention.

Footnotes

The authors report no competing interests.
This letter (doi: 10.1176/appi.ajp.2007.07091377) was accepted for publication in September 2007.

References

1.
Otte C, McCaffrey J, Ali S, Whooley MA: Association of serotonin transporter polymorphism (5-HTTLPR) with depression, perceived stress, and norepinephrine in patients with coronary disease: the Heart and Soul Study. Am J Psych 2007; 164:1379–1384
2.
Meredith IT, Broughton A, Jennings GL, Esler MD: Evidence of a selective increase in cardiac sympathetic activity in patients with sustained ventricular arrhythmias. N Engl J Med 1991; 325:618–624
3.
Schlaich MP, Kaye DM, Lambert E, Sommerville M, Socratous F, Esler MD: Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy. Circulation 2003; 108:560–565
4.
Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP: Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322:1561–1566
5.
Esler M, Jennings G, Lambert G: Measurement of overall and cardiac norepinephrine release into plasma during cognitive challenge. Psychoneuroendocrinology 1989; 14:477–481
6.
Barton DA, Dawood T, Lambert EA, Esler MD, Haikerwal D, Brenchley C, Socratous F, Kaye DM, Schlaich MP, Hickie I, Lambert GW: Sympathetic activity in major depressive disorder: identifying those at increased cardiac risk? J Hypertens 2007; 25:2117–2124

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 137
PubMed: 18178758

History

Published online: 1 January 2008
Published in print: January, 2008

Authors

Details

RICHARD G. BAYLES, Bc.S.
ELISABETH A. LAMBERT, Ph.D.
MARKUS P. SCHLAICH, M.D.
GAVIN W. LAMBERT, Ph.D.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share